These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 28183461)

  • 1. Management of No-Reflow Phenomenon in the Catheterization Laboratory.
    Rezkalla SH; Stankowski RV; Hanna J; Kloner RA
    JACC Cardiovasc Interv; 2017 Feb; 10(3):215-223. PubMed ID: 28183461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis.
    Niu X; Zhang J; Bai M; Peng Y; Sun S; Zhang Z
    BMC Cardiovasc Disord; 2018 Jan; 18(1):3. PubMed ID: 29320987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive Assessment of the Coronary Microcirculation in Reperfused ST-Segment-Elevation Myocardial Infarction Patients: Where Do We Stand?
    Bulluck H; Foin N; Tan JW; Low AF; Sezer M; Hausenloy DJ
    Circ Cardiovasc Interv; 2017 Mar; 10(3):. PubMed ID: 28242607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes of nicorandil administration in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials.
    Geng N; Ren L; Xu L; Zou D; Pang W
    BMC Cardiovasc Disord; 2021 Oct; 21(1):488. PubMed ID: 34629058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathogenesis and treatment of no-reflow occurring during percutaneous coronary intervention.
    Movahed MR; Butman SM
    Cardiovasc Revasc Med; 2008; 9(1):56-61. PubMed ID: 18206640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of syntax score and syntax score II to predict "no reflow phenomenon" in patients with ST-segment elevation myocardial infarction.
    Yesin M; Çağdaş M; Kalçık M; Uluganyan M; Efe SÇ; Rencüzoğulları İ; Karabağ Y; Gürsoy MO; Karakoyun S
    Int J Cardiovasc Imaging; 2017 Dec; 33(12):1883-1889. PubMed ID: 28664479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction.
    Gupta S; Gupta MM
    Indian Heart J; 2016; 68(4):539-51. PubMed ID: 27543480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New CHA
    Zhang QY; Ma SM; Sun JY
    BMC Cardiovasc Disord; 2020 Jul; 20(1):346. PubMed ID: 32711475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of endothelial dysfunction and no-reflow during primary percutaneous coronary intervention for ST-elevation myocardial infarction.
    Levi Y; Sultan A; Alemayehu M; Wall S; Lavi S
    Cardiovasc Revasc Med; 2016 Dec; 17(8):552-555. PubMed ID: 27638105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of platelet inhibition level on subsequent no-reflow in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Aitmokhtar O; Paganelli F; Benamara S; Azaza A; Bonello L; Hamza O; Seddiki S; Benathmane T; Saidane M; Bouzid A; Kara M; Sik A; Azzouz A; Harbi F; Monsuez JJ; Benkhedda S
    Arch Cardiovasc Dis; 2017 Nov; 110(11):626-633. PubMed ID: 28583820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of the no-reflow phenomenon.
    Butler MJ; Chan W; Taylor AJ; Dart AM; Duffy SJ
    Pharmacol Ther; 2011 Oct; 132(1):72-85. PubMed ID: 21664376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of nitroprusside versus nicorandil on the slow/no-reflow phenomenon during coronary interventions for acute myocardial infarction.
    Kobatake R; Sato T; Fujiwara Y; Sunami H; Yoshioka R; Ikeda T; Saito H; Ujihira T
    Heart Vessels; 2011 Jul; 26(4):379-84. PubMed ID: 21110199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impella CP and Veno-Arterial Extracorporeal Membrane Oxygenator as a sequential add-on combination circulatory support in ST-segment elevation myocardial infarction complicated by cardiogenic shock.
    Giuliani L; Archilletti F; Rossi S; Maddestra N
    Cardiovasc Revasc Med; 2019 Nov; 20(11S):60-62. PubMed ID: 31488363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictor of No-Reflow in Patients With ST-Segment Elevation Myocardial Infarction.
    Seçkin Göbüt Ö; Ünlü S
    Angiology; 2024 Aug; 75(7):696-697. PubMed ID: 37768690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of No-Reflow Phenomenon in Young Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Celik T; Balta S; Ozturk C; Kaya MG; Aparci M; Yildirim OA; Demir M; Unlu M; Demirkol S; Kilic S; Iyisoy A
    Angiology; 2016 Aug; 67(7):683-9. PubMed ID: 26369341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of ultrasound attenuation and plaque rupture as detected by intravascular ultrasound on the incidence of no-reflow phenomenon after percutaneous coronary intervention in ST-segment elevation myocardial infarction.
    Endo M; Hibi K; Shimizu T; Komura N; Kusama I; Otsuka F; Mitsuhashi T; Iwahashi N; Okuda J; Tsukahara K; Kosuge M; Ebina T; Umemura S; Kimura K
    JACC Cardiovasc Interv; 2010 May; 3(5):540-9. PubMed ID: 20488411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology and diagnosis of coronary microvascular dysfunction in ST-elevation myocardial infarction.
    Konijnenberg LSF; Damman P; Duncker DJ; Kloner RA; Nijveldt R; van Geuns RM; Berry C; Riksen NP; Escaned J; van Royen N
    Cardiovasc Res; 2020 Mar; 116(4):787-805. PubMed ID: 31710673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No-reflow: Still searching for that magic bullet.
    Gilchrist IC
    Catheter Cardiovasc Interv; 2010 Nov; 76(6):794. PubMed ID: 21104769
    [No Abstract]   [Full Text] [Related]  

  • 19. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
    Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of serum cystatin C levels with myocardial perfusion and cardiac functional recovery in patients with anterior wall ST elevation myocardial infarction treated with primary coronary intervention.
    Tang L; Fang ZF; Zhou SH; Tai S; Ahmed S; Huang F; Shen XQ; Zhao YS; Hu XQ
    Heart Vessels; 2016 Sep; 31(9):1456-66. PubMed ID: 26498756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.